IQVIA Holdings Inc. (0JDM.L)
| Previous close | 200.28 |
| Open | 200.95 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 199.66 - 201.00 |
| 52-week range | 166.56 - 240.96 |
| Volume | |
| Avg. volume | 2,849 |
| Market cap | 398.071M |
| Beta (5Y monthly) | 1.37 |
| PE ratio (TTM) | 0.36 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
IQVIA Appoints Richard Staub III President of Research & Development Solutions
RESEARCH TRIANGLE PARK, N.C., September 26, 2023--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced it has appointed Richard Staub III, currently senior advisor to the Chairman and CEO, as president of its Research & Development Solutions (R&DS) business unit.
- Business Wire
IQVIA Named a Leader in Pharmacovigilance Solutions in IDC MarketScape Report
RESEARCH TRIANGLE PARK, N.C., September 12, 2023--IQVIA™ (NYSE:IQV), a global provider of data, analytics, technology solutions and services to the life sciences industry, has been named a Leader in the IDC Marketscape Worldwide Life Science R&D Pharmacovigilance Solutions 2022 Vendor Assessment.
- Business Wire
IQVIA CFO Ron Bruehlman to Speak at Baird Global Healthcare Conference on September 13, 2023
RESEARCH TRIANGLE PARK, N.C., September 05, 2023--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Baird 2023 Global Healthcare Conference in New York City on Wednesday, September 13, 2023 at 10:50 a.m. ET.
